| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Oncorus Inc (NASDAQ: ONCR)
ONCR Technical Analysis
5
| As on 9th Jun 2023 ONCR STOCK Price closed @ 0.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.80 & Strong Sell for SHORT-TERM with Stoploss of 3.65 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ONCRSTOCK Price
| Open | 0.10 | Change | Price | % |
| High | 0.10 | 1 Day | -0.01 | -9.09 |
| Low | 0.09 | 1 Week | -0.12 | -54.55 |
| Close | 0.10 | 1 Month | -0.24 | -70.59 |
| Volume | 4981232 | 1 Year | -5.25 | -98.13 |
| 52 Week High 5.62 | 52 Week Low 0.10 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ONCR Daily Charts |
ONCR Intraday Charts |
Whats New @ Bazaartrend |
ONCR Free Analysis |
|
|
ONCR Important Levels Intraday
| RESISTANCE | 0.12 |
| RESISTANCE | 0.11 |
| RESISTANCE | 0.11 |
| RESISTANCE | 0.11 |
| SUPPORT | 0.09 |
| SUPPORT | 0.09 |
| SUPPORT | 0.09 |
| SUPPORT | 0.08 |
ONCR Forecast April 2024
| 4th UP Forecast | 5.4 |
| 3rd UP Forecast | 3.7 |
| 2nd UP Forecast | 2.65 |
| 1st UP Forecast | 1.6 |
| 1st DOWN Forecast | -1.4 |
| 2nd DOWN Forecast | -2.45 |
| 3rd DOWN Forecast | -3.5 |
| 4th DOWN Forecast | -5.2 |
ONCR Weekly Forecast
| 4th UP Forecast | 1.51 |
| 3rd UP Forecast | 1.06 |
| 2nd UP Forecast | 0.78 |
| 1st UP Forecast | 0.50 |
| 1st DOWN Forecast | -0.30 |
| 2nd DOWN Forecast | -0.58 |
| 3rd DOWN Forecast | -0.86 |
| 4th DOWN Forecast | -1.31 |
ONCR Forecast2024
| 4th UP Forecast | 11.03 |
| 3rd UP Forecast | 7.52 |
| 2nd UP Forecast | 5.36 |
| 1st UP Forecast | 3.19 |
| 1st DOWN Forecast | -2.99 |
| 2nd DOWN Forecast | -5.16 |
| 3rd DOWN Forecast | -7.32 |
| 4th DOWN Forecast | -10.83 |
Oncorus Inc ( NASDAQ USA Symbol : ONCR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ONCR Business Profile
Oncorus, Inc., a clinical stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through intratumoral injection; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. Oncorus, Inc. has a clinical trial collaboration and supply agreement with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 combined with Merck's cancer immunotherapy KEYTRUDA in its Phase 1 clinical trial in patients with solid tumors. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: 50 Hampshire Street, Cambridge, MA, United States, 02139
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service